Isbn: 9798187984879 - how drug discovery works: an essential guide for busy people on why making a new medicine is so hard (5 risultati)

Lingua: Inglese
Editore: Independently published, 2026
- Brossura
Da: PBShop.store US, Wood Dale, IL, U.S.A.PBShop.store US
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 14,37
Spedizione gratuitaSpedito in U.S.A.Quantità: Più di 20 disponibili
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Lingua: Inglese
Editore: Independently published, 2026
- Brossura
Da: PBShop.store UK, Fairford, GLOS, Regno UnitoPBShop.store UK
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 14,00
EUR 3,83 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
PAP. Condizione: New. New Book. Shipped from UK. Established seller since 2000.

Lingua: Inglese
Editore: Independently Published Jul 2026, 2026
- Brossura
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 15,09
EUR 30,50 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. Neuware - This book is a Weekend Pocketbook on Everything You Should Know About How New Medicines Are Made, the long, expensive, and uncertain journey from a promising idea to a drug in your hand. Written in everyday language, we explore why every pill in a medicine cabinet is a survivor of a brutal scientific obstacle course.Why is making a new medicine so hard We begin with the scale of the challenge: scientists may start with thousands of possible compounds, only to watch nearly all of them fail because they do not work, prove toxic, or cannot be manufactured reliably. We explore why the human body is not a simple machine, but a storm of proteins, signals, cells, organs, and feedback loops where one helpful molecule can also cause unexpected harm.We then follow the search for a starting point. How do scientists find the first molecule worth pursuing We discuss old-fashioned serendipity, high-throughput screening, rational drug design, artificial intelligence (AI), natural products, existing drug libraries, and deoxyribonucleic acid (DNA)-encoded libraries. Along the way, we ask how researchers design a chemical 'key' for a biological 'lock,' and why even a brilliant early hit is still only the beginning.The book also explores the rise of new kinds of medicine. We move beyond traditional small molecules into biologics, monoclonal antibodies, antibody-drug conjugates, chimeric antigen receptor T cell (CAR T cell) therapy, messenger ribonucleic acid (mRNA) vaccines, gene therapy, clustered regularly interspaced short palindromic repeats (CRISPR), and ribonucleic acid (RNA) interference.…

Lingua: Inglese
Editore: Independently published, 2026
- Brossura
- Print on Demand
Da: California Books, Miami, FL, U.S.A.California Books
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 13,29
Spedizione gratuitaSpedito in U.S.A.Quantità: Più di 20 disponibili
Condizione: New. Print on Demand.

Lingua: Inglese
Editore: Independently Published, 2026
- Brossura
- Print on Demand
Da: CitiRetail, Stevenage, Regno UnitoCitiRetail
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 17,38
EUR 43,10 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: new. Paperback. This book is a Weekend Pocketbook on Everything You Should Know About How New Medicines Are Made, the long, expensive, and uncertain journey from a promising idea to a drug in your hand. Written in everyday language, we explore why every pill in a medicine cabinet is a survivor of a brutal scientific obstacle course.Why is making a new medicine so hard? We begin with the scale of the challenge: scientists may start with thousands of possible compounds, only to watch nearly all of them fail because they do not work, prove toxic, or cannot be manufactured reliably. We explore why the human body is not a simple machine, but a storm of proteins, signals, cells, organs, and feedback loops where one helpful molecule can also cause unexpected harm.We then follow the search for a starting point. How do scientists find the first molecule worth pursuing? We discuss old-fashioned serendipity, high-throughput screening, rational drug design, artificial intelligence (AI), natural products, existing drug libraries, and deoxyribonucleic acid (DNA)-encoded libraries. Along the way, we ask how researchers design a chemical "key" for a biological "lock," and why even a brilliant early hit is still only the beginning.The book also explores the rise of new kinds of medicine. We move beyond traditional small molecules into biologics, monoclonal antibodies, antibody-drug conjugates, chimeric antigen receptor T cell (CAR T cell) therapy, messenger ribonucleic acid (mRNA) vaccines, gene therapy, clustered regularly interspaced short palindromic repeats (CRISPR), and ribonucleic acid (RNA) interference. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…